3D-QSAR analysis of a series of S-DABO derivatives as anti-HIV agents by CoMFA and CoMSIA.

about

3D-QSAR analysis of a series of S-DABO derivatives as anti-HIV agents by CoMFA and CoMSIA.

Item

http://www.wikidata.org/entity/Q40566306

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

3D-QSAR analysis of a series o ...... IV agents by CoMFA and CoMSIA.

@en

type

Item

label

3D-QSAR analysis of a series o ...... IV agents by CoMFA and CoMSIA.

@en

prefLabel

3D-QSAR analysis of a series o ...... IV agents by CoMFA and CoMSIA.

@en

P1476

3D-QSAR analysis of a series o ...... IV agents by CoMFA and CoMSIA.

@en

P2093

H R Xu

http://www.w3.org/2001/XMLSchema#string

L Fu

http://www.w3.org/2001/XMLSchema#string

P Zhan

http://www.w3.org/2001/XMLSchema#string

X Y Liu

http://www.w3.org/2001/XMLSchema#string

P2860

5-Alkyl-2-(alkylthio)-6-(2,6-dihalophenylmethyl)-3, 4-dihydropyrimidin-4(3H)-ones: novel potent and selective dihydro-alkoxy-benzyl-oxopyrimidine derivatives

Dihydro-alkylthio-benzyl-oxopyrimidines as inhibitors of reverse transcriptase: synthesis and rationalization of the biological data on both wild-type enzyme and relevant clinical mutants.

Rational selection of training and test sets for the development of validated QSAR models.

Novel HIV-1 reverse transcriptase inhibitors.

Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV.

Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: a review of the last 20 years (1989-2009).

Novel tight binding PETT, HEPT and DABO-based non-nucleoside inhibitors of HIV-1 reverse transcriptase.

In search of a selective therapy of viral infections.

Antiretroviral drugs.

Design, synthesis, and biological evaluation of novel 5-Alkyl-6-Adamantylmethylpyrimidin-4(3H)-ones as HIV-1 non-nucleoside reverse-transcriptase inhibitors.

P304

999-1014

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/1062936X.2016.1233580

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27667445

http://www.w3.org/2001/XMLSchema#string